BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33472068)

  • 1. HDAC inhibition results in widespread alteration of the histone acetylation landscape and BRD4 targeting to gene bodies.
    Slaughter MJ; Shanle EK; Khan A; Chua KF; Hong T; Boxer LD; Allis CD; Josefowicz SZ; Garcia BA; Rothbart SB; Strahl BD; Davis IJ
    Cell Rep; 2021 Jan; 34(3):108638. PubMed ID: 33472068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone cross-talk connects protein phosphatase 1α (PP1α) and histone deacetylase (HDAC) pathways to regulate the functional transition of bromodomain-containing 4 (BRD4) for inducible gene expression.
    Hu X; Lu X; Liu R; Ai N; Cao Z; Li Y; Liu J; Yu B; Liu K; Wang H; Zhou C; Wang Y; Han A; Ding F; Chen R
    J Biol Chem; 2014 Aug; 289(33):23154-23167. PubMed ID: 24939842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs).
    Mackmull MT; Iskar M; Parca L; Singer S; Bork P; Ori A; Beck M
    Mol Cell Proteomics; 2015 May; 14(5):1350-60. PubMed ID: 25755299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging roles of HDACs and their therapeutic implications in cancer.
    Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X
    Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution.
    Gao M; Wang J; Rousseaux S; Tan M; Pan L; Peng L; Wang S; Xu W; Ren J; Liu Y; Spinck M; Barral S; Wang T; Chuffart F; Bourova-Flin E; Puthier D; Curtet S; Bargier L; Cheng Z; Neumann H; Li J; Zhao Y; Mi JQ; Khochbin S
    Cell Rep; 2021 Jul; 36(4):109460. PubMed ID: 34320364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylases maintain expression of the pluripotent gene network via recruitment of RNA polymerase II to coding and noncoding loci.
    Kelly RDW; Stengel KR; Chandru A; Johnson LC; Hiebert SW; Cowley SM
    Genome Res; 2024 Feb; 34(1):34-46. PubMed ID: 38290976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells.
    Gonzales-Cope M; Sidoli S; Bhanu NV; Won KJ; Garcia BA
    BMC Genomics; 2016 Feb; 17():95. PubMed ID: 26847871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.
    Zhang W; Prakash C; Sum C; Gong Y; Li Y; Kwok JJ; Thiessen N; Pettersson S; Jones SJ; Knapp S; Yang H; Chin KC
    J Biol Chem; 2012 Dec; 287(51):43137-55. PubMed ID: 23086925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
    Obier N; Uhlemann CF; Müller AM
    Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylases as targets in autoimmune and autoinflammatory diseases.
    Hamminger P; Rica R; Ellmeier W
    Adv Immunol; 2020; 147():1-59. PubMed ID: 32981634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y; Seto E
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes.
    Wang Z; Zang C; Cui K; Schones DE; Barski A; Peng W; Zhao K
    Cell; 2009 Sep; 138(5):1019-31. PubMed ID: 19698979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators.
    Rafehi H; Karagiannis TC; El-Osta A
    Curr Top Med Chem; 2017; 17(14):1611-1622. PubMed ID: 27823568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zac1 is a histone acetylation-regulated NF-κB suppressor that mediates histone deacetylase inhibitor-induced apoptosis.
    Shu G; Tang Y; Zhou Y; Wang C; Song JG
    Cell Death Differ; 2011 Dec; 18(12):1825-35. PubMed ID: 21546906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.
    Nagashima T; Maruyama T; Furuya M; Kajitani T; Uchida H; Masuda H; Ono M; Arase T; Ozato K; Yoshimura Y
    Mol Hum Reprod; 2007 Mar; 13(3):141-8. PubMed ID: 17267518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase (HDACs) inhibitors: Clinical applications.
    Shanmukha KD; Paluvai H; Lomada SK; Gokara M; Kalangi SK
    Prog Mol Biol Transl Sci; 2023; 198():119-152. PubMed ID: 37225317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone acetylation and the cell-cycle in cancer.
    Wang C; Fu M; Mani S; Wadler S; Senderowicz AM; Pestell RG
    Front Biosci; 2001 Apr; 6():D610-29. PubMed ID: 11282573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation.
    Naruse Y; Oh-hashi K; Iijima N; Naruse M; Yoshioka H; Tanaka M
    Mol Cell Biol; 2004 Jul; 24(14):6278-87. PubMed ID: 15226430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.